Kenvue, the American company that makes Tylenol, says the US Food and Drug Administration should not make proposed changes to ...
Kenvue urged the Food and Drug Administration to deny a proposal to add further warnings to acetaminophen products after the ...
Kenvue has urged U.S. regulators to reject a request seeking autism warning label on its popular over-the-counter pain ...
Barchart on MSN
Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.
Kenvue (KVUE) could really use some good news. The Johnson & Johnson (JNJ) spinoff faced longlasting troubles regarding its ...
In February 2017, it advised another social media user — who had praised Tylenol "for being pregnancy safe" — to seek a clinician’s advice: "Thanks for the shout out Carrie!" Tylenol wrote. "Just make ...
Barchart on MSN
This Billionaire Investor Is ‘Thrilled’ to Own Kenvue Stock Despite Tylenol Turbulence. Should You Buy KVUE Here?
Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during ...
Tylenol's social media post from 8 years ago is being resurfaced amid the White House's comments linking the drug to autism.
An old social media post sent by Tylenol warning consumers not to use “any of our products while pregnant” has resurfaced, ...
Last month, Trump warned of a link between autism and acetaminophen use in pregnancy, going against advice from medical ...
Views Staff Writer Ryleigh Beller argues that medical misinformation fuels fear, lowers trust in science, and endangers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results